GreenLight Biosciences Holdings, PBC Common Stock
GRNA
GRNA was delisted on the 21st of July, 2023.
60 hedge funds and large institutions have $15.7M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 9 closing their positions.
6% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 17
0% more funds holding
Funds holding: 60 → 60 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
65% less capital invested
Capital invested by funds: $44.4M → $15.7M (-$28.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$197K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$111K |
| 3 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$77.4K |
| 4 |
CWM
Congress Wealth Management
Boston,
Massachusetts
|
+$69.1K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$64.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$452K |
| 2 |
BlackRock
New York
|
-$264K |
| 3 |
ROTUOC
Regents of the University of California
Oakland,
California
|
-$234K |
| 4 |
Swiss National Bank
Zurich,
Switzerland
|
-$216K |
| 5 |
BNP Paribas Asset Management
Paris,
France
|
-$192K |
GRNA Hedge Fund Activity: Q1 2023 in Review
60 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q1 2023, worth a combined $15.7M — down 65% from $44.4M a quarter earlier.
Fund positioning in GRNA was balanced in Q1 2023: 9 funds opened new positions, 9 closed out, 18 added to existing stakes and 17 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $197K. The largest seller was Baird Financial Group, cutting an estimated $452K.
- 60 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $15.7M of GreenLight Biosciences Holdings, PBC Common Stock stock for Q1 2023, down 65% quarter-over-quarter.
- 9 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q1 2023 and 9 closed out, a net change of 0 holders.
- The largest GreenLight Biosciences Holdings, PBC Common Stock buyer in Q1 2023 was Renaissance Technologies, an estimated $197K added.
- The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q1 2023 was Baird Financial Group, an estimated $452K sold.
Based on aggregated 13F filings for Q1 2023.